FDA Evaluates Topical Acne Ingredients After Adverse Event Report Jump
This article was originally published in The Tan Sheet
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
You may also be interested in...
CDER recommends the OTC industry ensure product innovations comply with monographs or have FDA approval prior to marketing. Umbrella-branding and facility registration rank high for the drug center in 2013.
FDA's recommendation for complete addresses on OTC and dietary supplement product labels in order to comply with the adverse event reporting law exceeds not only Congress's intent, but also the requirements for all other products regulated by the agency, industry groups say
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.